Antonio Bertoletti

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 35

Top Venues

Cellular & molecular immunology

Nature communications

Gut

Oxford open immunology

Duke-NUS Medical School

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Duke-NUS Medical School

Singapore

Professor :: Emerging Infectious Diseases

Agency for Science Technology and Research

Singapore

Director Infection and Immunity :: Singapore Institute for Clinical Sciences

University College London

United Kingdom

Reader :: Institute of Hepatology

Publications

Antonio Bertoletti
SARS-CoV-2 immunity. Cellular & molecular immunology 21 (2) (2024)
Antonio Bertoletti
SARS-CoV-2 immunity. Cellular & molecular immunology 21 (2) (2024)
Antonio Bertoletti
SARS-CoV-2 immunity. Cellular & molecular immunology 21 (2) (2024)
Antonio Bertoletti
SARS-CoV-2 immunity. Cellular & molecular immunology 21 (2) (2024)
Antonio Bertoletti
SARS-CoV-2 immunity. Cellular & molecular immunology 21 (2) (2024)
Antonio Bertoletti
The immune response in chronic HBV infection. Journal of viral hepatitis (2024)
Antonio Bertoletti
SARS-CoV-2 immunity. Cellular & molecular immunology (2024)
Bernice Ling Zhi Oh, Noriko Shimasaki, Elaine Coustan-Smith, Esther Chan, Limei Poon, Shawn H R Lee, Frances Yeap, Lip Kun Tan, Louis Y A Chai, Nina Le Bert, Nicole Tan, Antonio Bertoletti, Siew Peng Chen, Francesca Del Bufalo, Marco Becilli, Franco Locatelli, Allen Eng-Juh Yeoh, Dario Campana
Fratricide-resistant CD7-CAR T cells in T-ALL. Nature medicine (2024)
Antonio Bertoletti
SARS-CoV-2 immunity. Cellular & molecular immunology 21 (2) (2024)
Maxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, Joey J Y Aw, Damien Zhi Ming Tan, Ragavi Vijayakumar, Erica Ceccarello, Tommaso Tabaglio, Yan Ting Lim, Wang Loo Chien, Fritz Lai, Anthony Tan Tanoto, Qingfeng Chen, Radoslaw Mikolaj Sobota, Giulia Adriani, Antonio Bertoletti, Ernesto Guccione, Andrea Pavesi
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nature communications 14 (1) (2023)
Maxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, Joey J Y Aw, Damien Zhi Ming Tan, Ragavi Vijayakumar, Erica Ceccarello, Tommaso Tabaglio, Yan Ting Lim, Wang Loo Chien, Fritz Lai, Anthony Tan Tanoto, Qingfeng Chen, Radoslaw Mikolaj Sobota, Giulia Adriani, Antonio Bertoletti, Ernesto Guccione, Andrea Pavesi
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nature communications 14 (1) (2023)
Qi Chen, Adeline Chia, Shou Kit Hang, Amy Lim, Wee Kun Koh, Yanchun Peng, Fei Gao, Jili Chen, Zack Ho, Lu-En Wai, Kamini Kunasegaran, Anthony Tanoto Tan, Nina Le Bert, Chiew Yee Loh, Yun Shan Goh, Laurent Renia, Tao Dong, Anantharaman Vathsala, Antonio Bertoletti
Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy. Cellular & molecular immunology (2023)
Meiyin Lin, Sebastian Chakrit Bhakdi, Damien Tan, Joycelyn Jie Xin Lee, David Wai Meng Tai, Andrea Pavesi, Lu-En Wai, Tina Wang, Antonio Bertoletti, Anthony Tanoto Tan
Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole blood. Immunotherapy advances 3 (1) (2023)
Maxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, Joey J Y Aw, Damien Zhi Ming Tan, Ragavi Vijayakumar, Erica Ceccarello, Tommaso Tabaglio, Yan Ting Lim, Wang Loo Chien, Fritz Lai, Anthony Tan Tanoto, Qingfeng Chen, Radoslaw Mikolaj Sobota, Giulia Adriani, Antonio Bertoletti, Ernesto Guccione, Andrea Pavesi
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nature communications 14 (1) (2023)
Maxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, Joey J Y Aw, Damien Zhi Ming Tan, Ragavi Vijayakumar, Erica Ceccarello, Tommaso Tabaglio, Yan Ting Lim, Wang Loo Chien, Fritz Lai, Anthony Tan Tanoto, Qingfeng Chen, Radoslaw Mikolaj Sobota, Giulia Adriani, Antonio Bertoletti, Ernesto Guccione, Andrea Pavesi
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nature communications 14 (1) (2023)
Antonio Bertoletti, Nina Le Bert
Quest for immunological biomarkers in the management of CHB patients. Gut (2023)
Maxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, Joey J Y Aw, Damien Zhi Ming Tan, Ragavi Vijayakumar, Erica Ceccarello, Tommaso Tabaglio, Yan Ting Lim, Wang Loo Chien, Fritz Lai, Anthony Tan Tanoto, Qingfeng Chen, Radoslaw Mikolaj Sobota, Giulia Adriani, Antonio Bertoletti, Ernesto Guccione, Andrea Pavesi
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma. Nature communications 14 (1) (2023)
Zhong Fang, Yi Zhang, Zhaoqin Zhu, Cong Wang, Yao Hu, Xiuhua Peng, Dandan Zhang, Jun Zhao, Bisheng Shi, Zhongliang Shen, Min Wu, Chunhua Xu, Jieliang Chen, Xiaohui Zhou, You-Hua Xie, Hui Yu, Xiao-Nan Zhang, Jianhua Li, Yunwen Hu, Maya Kozlowski, Antonio Bertoletti, Zhenghong Yuan
Monocytic MDSCs homing to thymus contribute to age-related CD8+ T cell tolerance of HBV. The Journal of experimental medicine 219 (4) (2022)
Antonio Bertoletti, Nina Le Bert, Anthony T Tan
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization. International journal of molecular sciences 23 (18) (2022)
Megan Schwarz, Denis Torre, Daniel Lozano-Ojalvo, Anthony T Tan, Tommaso Tabaglio, Slim Mzoughi, Rodrigo Sanchez-Tarjuelo, Nina Le Bert, Joey Ming Er Lim, Sandra Hatem, Kevin Tuballes, Carmen Camara, Eduardo Lopez-Granados, Estela Paz-Artal, Rafael Correa-Rocha, Alberto Ortiz Arduan, Marcos Lopez-Hoyos, Jose M Portolés, Isabel Cervera, Maria Gonzalez-Perez, Irene Bodega-Mayor, Patricia Conde, Jesús Oteo-Iglesias, Alberto M Borobia, Antonio J Carcas, Jesús Frías, Cristóbal Belda-Iniesta, Jessica Sook Yuin Ho, Kemuel Nunez, Saboor Hekmaty, Kevin Mohammed, William M Marsiglia, Juan Manuel Carreño, Arvin C Dar, Cecilia Berin, Giuseppe Nicoletti, Isabella Della Noce, Lorenzo Colombo, Cristina Lapucci, Graziano Santoro, Maurizio Ferrari, Kai Nie, Manishkumar Patel, Vanessa Barcessat, Sacha Gnjatic, Jocelyn Harris, Robert Sebra, Miriam Merad, Florian Krammer, Seunghee Kim-Schulze, Ivan Marazzi, Antonio Bertoletti, Jordi Ochando, Ernesto Guccione
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR. Nature biotechnology 40 (11) (2022)
Joey Ming Er Lim, Anthony Tanoto Tan, Nina Le Bert, Shou Kit Hang, Jenny Guek-Hong Low, Antonio Bertoletti
SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity. The Journal of experimental medicine 219 (10) (2022)
Bernice Ling Zhi Oh, Nicole Tan, Ruklanthi de Alwis, Kamini Kunasegaran, Zhiwei Chen, Michelle Poon, Esther Chan, Jenny G H Low, Allen Eng-Juh Yeoh, Antonio Bertoletti, Nina Le Bert
Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell-treated patients. Blood 140 (2) (2022)
Antonio Bertoletti, Carolina Boni
HBV antigens quantity: duration and effect on functional cure. Gut (2021)
Antonio Bertoletti, Anthony T Tan, Nina Le Bert
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role. Oxford open immunology 2 (1) (2021)
Leo Swadling, Mariana O Diniz, Nathalie M Schmidt, Oliver E Amin, Aneesh Chandran, Emily Shaw, Corinna Pade, Joseph M Gibbons, Nina Le Bert, Anthony T Tan, Anna Jeffery-Smith, Cedric C S Tan, Christine Y L Tham, Stephanie Kucykowicz, Gloryanne Aidoo-Micah, Joshua Rosenheim, Jessica Davies, Marina Johnson, Melanie P Jensen, George Joy, Laura E McCoy, Ana M Valdes, Benjamin M Chain, David Goldblatt, Daniel M Altmann, Rosemary J Boyton, Charlotte Manisty, Thomas A Treibel, James C Moon, null null, Lucy van Dorp, Francois Balloux, Áine McKnight, Mahdad Noursadeghi, Antonio Bertoletti, Mala K Maini
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. Nature (2021)
Antonio Bertoletti, Nina Le Bert, Martin Qui, Anthony T Tan
SARS-CoV-2-specific T cells in infection and vaccination. Cellular & molecular immunology 18 (10) (2021)
Morteza Hafezi, Meiyin Lin, Adeline Chia, Alicia Chua, Zi Zong Ho, Royce Fam, Damien Tan, Joey Aw, Andrea Pavesi, Thinesh Lee Krishnamoorthy, Wan Cheng Chow, Wenjie Chen, Qi Zhang, Lu-En Wai, Sarene Koh, Anthony T Tan, Antonio Bertoletti
Immunosuppressive Drug-Resistant Armored T-Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients. Hepatology (Baltimore, Md.) 74 (1) (2021)
Antonio Bertoletti
ImmTAV, a New Immunotherapy Targeting the Source of HBV Infection. Hepatology (Baltimore, Md.) 72 (5) (2021)
Antonio Bertoletti, Anthony T Tan, Nina Le Bert
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role. Oxford open immunology 2 (1) (2021)
Anthony T Tan, Antonio Bertoletti
HBV-HCC treatment with mRNA electroporated HBV-TCR T cells. Immunotherapy advances 2 (1) (2021)
Nina Le Bert, Anthony T Tan, Kamini Kunasegaran, Christine Y L Tham, Morteza Hafezi, Adeline Chia, Melissa Hui Yen Chng, Meiyin Lin, Nicole Tan, Martin Linster, Wan Ni Chia, Mark I-Cheng Chen, Lin-Fa Wang, Eng-Eong Ooi, Shirin Kalimuddin, Paul Anantharajah Tambyah, Jenny Guek-Hong Low, Yee-Joo Tan, Antonio Bertoletti
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 584 (7821) (2020)
Antonio Bertoletti, Patrick T F Kennedy
HBV antiviral immunity: not all CD8 T cells are born equal. Gut 68 (5) (2019)
Antonio Bertoletti, Nina Le Bert
Fine-Tuning TLR-7-Based Therapy for Functional HBV Cure. Hepatology communications 3 (10) (2019)
Gregory C Fanning, Fabien Zoulim, Jinlin Hou, Antonio Bertoletti
Therapeutic strategies for hepatitis B virus infection: towards a cure. Nature reviews. Drug discovery 18 (11) (2019)
Antonio Bertoletti, Patrick T F Kennedy, David Durantel
HBV infection and HCC: the 'dangerous liaisons'. Gut 67 (5) (2017)

Antonio Bertoletti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Antonio Bertoletti